Levodopa increases pain threshold in Parkinson's disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1525, 2006-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa/carbidopa and Parkinson's disease progression

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinson's Disease

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-01 ,pp. : 234-243

Bentham Science Publishers

Access to resources Recommend Favorite

Alternatives to Levodopa in the Initial Treatment of Early Parkinson’s Disease

By Lees Andrew  

Drugs & Aging, Vol. 22, Iss. 9, 2005-01 ,pp. : 731-740

Adis International

Access to resources Recommend Favorite

Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness

By Noyes Katia   Dick Andrew W.   Holloway Robert G.   The Parkinson Study Group  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1257-1270

Adis International

Access to resources Recommend Favorite